Clinical Practice Guideline: Ménière’s Disease
Gregory J. Basura(University of Michigan), Erin Michelle Buchanan(American Academy of Otolaryngology — Head and Neck Surgery), Kevin A. Kerber(University of Michigan), Patrick J. Antonelli(University of Florida), Evie G. Marcolini(Dartmouth College), Julie Bykowski(University of California San Diego), Maria Colandrea(Duke University), Amy Angie Kuch, Elizabeth A. Kelly(Pennsylvania State University), Michael J. Ruckenstein(University of Pennsylvania), Nui Dhepyasuwan(American Academy of Otolaryngology — Head and Neck Surgery), Charles F. Koopman(C. S. Mott Children's Hospital), Sandra A. Walsh(Consumers Union), Brian J. McKinnon(Drexel University), Meredith E. Adams(University of Minnesota), Robert Burkard(University at Buffalo, State University of New York), Matthew L. Bush(University of Toledo), Carla V. Valenzuela(Washington University in St. Louis), Ashkan Monfared(George Washington University), Lorraine C. Nnacheta(American Academy of Otolaryngology — Head and Neck Surgery), Seth Schwartz(Virginia Mason Medical Center), Jennifer Derebery(House Clinic), Alexis Vosooney(Minnesota West Community & Technical College)
Cited by 301
Related Papers
Clinical Practice Guideline
|Otolaryngology|2012|919
Clinical Practice Guideline: Sudden Hearing Loss (Update)
|Otolaryngology|2019|918
Clinical Practice Guideline: Hoarseness (Dysphonia)
|Otolaryngology|2009|446
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
|The Lancet Oncology|2021|257
Clinical Consensus Statement: Ankyloglossia in Children
|Otolaryngology|2020|186